Influence of glucagon-like peptide-1 receptor agonists on renal parameters: a meta-analysis of randomized controlled trials
Li W, Liang X, Sun N, Zhang D
BMC Endocr Disord. 2025;25(1):124.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Dietary Approaches to Stop Hypertension (DASH) for the primary and secondary prevention of cardiovascular diseases
Bensaaud A, Seery S, Gibson I, et al.
Cochrane Database Syst Rev. 2025;5(5):CD013729.
Abstract
Leggi
Cellular versus acellular matrix products for diabetic foot ulcer treatment: the Dermagraft and Oasis Longitudinal Comparative Efficacy Study (DOLCE) – a randomized clinical trial
Shawa H, Kaur R, Tchanque-Fossuo C, et al.
Diabetes Care. 2025:dc241233.
Leggi
The obesity paradox in cognitive decline: Impact of BMI dynamics and APOE genotypes across various cognitive status
Zhai W, Zhang G, Wei C, et al.
Diabetes Obes Metab. Pub. online 2 May 2025.
Leggi
Aetiology of type 2 diabetes: an experimental medicine odyssey
Taylor R
Diabetologia. Pub. online 2 May 2025.
Leggi
Duration and type of statin use and long-term risk of type 2 diabetes among men and women with hypercholesterolaemia: findings from three prospective cohorts
Zhang Y, Li Y, Liu Y, et al.
Diabetologia. Pub. online 2 May 2025.
Leggi
Long-term effects of metformin on offspring health: a review of current evidence and future directions
Mayadunne T, Saadati S, Asmelash D, Mason T, et al.
Diabetes Obes Metab. Pub. online 6 May 2025.
Leggi
Comparative efficacy and safety of SGLT2 inhibitor class members in patients with heart failure and type 2 diabetes: a systematic review and network meta-analysis of randomized controlled trials
Su AY, Csere MM, Shan R, et al.
Diabetes Res Clin Pract. 2025:112219.
Leggi
Tirzepatide 10 and 15 mg versus semaglutide 2.4 mg in people with obesity or overweight with type 2 diabetes: an indirect treatment comparison
Hankosky ER, He X, Malik R, et al.
Diabetes Obes Metab. Pub. online 5 May 2025.
Leggi
Glucagon-like peptide 1 (GLP-1) receptor agonists’ use during pregnancy: safety data from regulatory clinical trials
Parker CH, Slattery C, Brennan DJ, le Roux CW
Diabetes Obes Metab. Pub. online 6 May 2025.
Leggi